24 results
8-K
EX-10.1
COYA
Coya Therapeutics Inc
20 May 24
Coya Therapeutics Announces $5 Million Strategic
5:00pm
, including without limitation all applicable foreign, federal, state and local laws relating to taxes, environmental protection, occupational health … in a Material Adverse Effect.
(m) Environmental Laws. Except as set forth in the SEC Reports, the Company and its Subsidiaries (i) are in compliance
D
COYA
Coya Therapeutics Inc
20 Dec 23
$26.48 mm in equity / options / securities to be acquired, sold $26.48 mm, 122 investors
9:46am
Environmental Services
Oil & Gas
Other Energy
Health Care
Biotechnology
Health Insurance
Hospitals & Physicians
Pharmaceuticals
Other Health
8-K
EX-10.1
4bp17i
6 Dec 23
Entry into a Material Definitive Agreement
7:30am
8-K
EX-99.1
n2g b7hu8nv
6 Dec 23
Entry into a Material Definitive Agreement
7:30am
DEF 14A
3ro02rzkrgjfmafhr1
19 May 23
Definitive proxy
4:31pm
10-Q
EX-10.1
rgj yogqw4
10 May 23
Quarterly report
7:14am
10-K
8wnt ohbbagtgjoe
29 Mar 23
Annual report
4:08pm
424B4
cc5lek f9
30 Dec 22
Prospectus supplement with pricing info
4:17pm
S-1/A
a9hs ehtpq5g4yo1
5 Dec 22
IPO registration (amended)
8:16am
S-1
EX-2.1
3zxo fz9h
18 Nov 22
IPO registration
5:06pm
S-1
itukccmb
18 Nov 22
IPO registration
5:06pm
DRS/A
2v17htxz9
28 Oct 22
Draft registration statement (amended)
12:00am
DRS/A
EX-2
2munvocmhfo9w3
7 Oct 22
Draft registration statement (amended)
12:00am
DRSLTR
ulqxw
7 Oct 22
Correspondence regarding draft registration statement
12:00am
DRS/A
2xv0rxwc
7 Oct 22
Draft registration statement (amended)
12:00am